Press Releases
eTheRNA Manufacturing Announces New LNP Formulation Development and Production Service
eTheRNA Manufacturing, a specialist RNA process developer and manufacturing member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and early pre-clinical development of RNA-based therapeutics and...
Press Releases
Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets
Sanofi and IGM Biosciences, Inc. announced the signing of an exclusive worldwide collaboration agreement to create, develop, manufacture, and commercialize IgM antibody agonists against three oncology targets and three immunology/inflammation targets. Engineered IgM antibodies represent a new class of...
Press Releases
Boehringer Ingelheim selects Veeva Development Cloud worldwide to bring innovative therapies to patients faster
Boehringer Ingelheim and Veeva Systems announce Boehringer Ingelheim’s selection of Veeva Development Cloud to drive end-to-end processes and seamless information sharing enterprise wide for greater speed in the delivery of innovative therapies. Boehringer Ingelheim, a leading research-driven biopharmaceutical company,...
Press Releases
Rentschler Biopharma and Vetter Unveil Xpert Alliance
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced that the companies are unveiling Xpert Alliance, a joint visualization of their strategic collaboration. The visualization is designed to “bring to life” this ongoing alliance...
Press Releases
BiologIC Technologies and Oxford Biomedica collaborate on novel biocomputer system for viral vector development
BiologIC Technologies, the biocomputer company, has announced today that it has entered into an agreement with Oxford Biomedica, a leading gene and cell therapy group, to collaborate on a novel biocomputer system for viral vector development.
BiologIC is the inventor...
Press Releases
Innovent and Lilly Expand Strategic Partnership in Oncology
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and Eli Lilly and Company ("Lilly",NYSE: LLY) today announced that in light of both...
Packaging & Labelling
Gerresheimer opens a new plant to produce pharmaceutical container solutions in Ohio (Berlin)
Gerresheimer ceremoniously took over a new building in Berlin, Ohio. In the future, the square plastic containers of the Duma Twist-Off Q brand with a 40-ml filling volume, child-resistant closure, and desiccant for filling with medications for the North...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















